Key result
Cervical cancer mortality in women with HF declined ~1% annually overall but reversed after 2009.
Why the study?
Cervical cancer and heart failure co-occur and complicate outcomes via shared risk factors and cardiotoxicity, prompting examination of mortality trends and disparities to guide integrated management strategies.
Observational (n=5,534)
Yes
Answers are grounded in this paper and cite their sources.
While cervical cancer mortality in heart failure patients declined overall from 1999 to 2020, a concerning upward trend since 2009 highlights the need for integrated care and continued screening.
e17524 Background: Cervical cancer remains one of the leading causes of female cancer mortality, while heart failure drives chronic disease burden. Their coexistence complicates outcomes through shared risk factors, cardiotoxicity, and mortality. This study examined cervical cancer mortality trends in patients with heart failure, assessed disparities, and aimed to inform integrated management strategies. Methods: We analyzed death certificates from CDC WONDER Database (1999–2020), using ICD-10 C53 (cervical cancer) and I50 (heart failure). Female mortality was stratified by race and urbanization. Joinpoint Regression Program V5.4.0 calculated Annual Percent Change (APC) and Average Annual Percent Change (AAPC). Results: A total of 5,534 deaths were identified. Age-adjusted mortality rates (AAMR) declined overall, but trends varied. Among females, mortality fell from 0.1102 per 100,000 in 1999 to 0.076 in 2020 (AAPC -1.28%). Three phases emerged: a modest decline (1999-2006, APC -1.45%), a rapid decline (2006-2009, APC -17.6%), and a concerning reversal (2009-2020, APC +3.27%). The latter increase may reflect reduced screening, declining vaccination rates, or COVID-19 disruptions.By urbanization, large central metropolitan areas showed a steady decline (APC -4.13%). By race, White women demonstrated a consistent reduction (APC -2.61%), indicating sustained benefits of screening and vaccination. Conclusions: Cervical cancer mortality in heart failure patients declined from 1999-2020, reflecting prevention and healthcare advances. However, disparities persist, with notable increases among women since 2009. These findings highlight successes but stress the urgent need for vaccination and screening.
No takes yet. Share an insight, caveat, or question.
Sehbai et al. (2026) conducted an observational in Cervical cancer and heart failure (n=5,534). Age-adjusted mortality for cervical cancer in females with heart failure declined from 0.1102 to 0.076 per 100,000 between 1999 and 2020, with a concerning reversal since 2009.
Synapse has enriched 10 related papers. Consider them for comparative context: